USP15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.720400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.513200E-01
Normal-vs-Stage2
3.849600E-01
Normal-vs-Stage3
2.784200E-01
Normal-vs-Stage4
3.801200E-01
Stage1-vs-Stage2
6.166600E-01
Stage1-vs-Stage3
2.939000E-01
Stage1-vs-Stage4
7.154600E-01
Stage2-vs-Stage3
1.654450E-01
Stage2-vs-Stage4
9.238600E-01
Stage3-vs-Stage4
1.835590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.755000E-01
Normal-vs-AfricanAmerican
3.589600E-01
Normal-vs-Asian
3.106800E-01
Caucasian-vs-AfricanAmerican
7.231200E-01
Caucasian-vs-Asian
1.770640E-01
AfricanAmerican-vs-Asian
5.950200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.695600E-01
Normal-vs-Female
3.769200E-01
Male-vs-Female
7.958400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.811800E-01
Normal-vs-Age(41-60Yrs)
4.236400E-01
Normal-vs-Age(61-80Yrs)
3.513600E-01
Normal-vs-Age(81-100Yrs)
3.641400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.504800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.609800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.054600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.157800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.554000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.760000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.353200E-01
Normal-vs-Daily Drinker
3.294400E-01
Normal-vs-Weekly Drinker
3.541600E-01
Normal-vs-Occasional Drinker
3.797400E-01
Normal-vs-Social Drinker
3.879600E-01
Non Drinker-vs-Daily Drinker
8.693800E-01
Non Drinker-vs-Weekly Drinker
7.756000E-01
Non Drinker-vs-Occasional Drinker
3.619400E-01
Non Drinker-vs-Social Drinker
2.829800E-01
Daily Drinker-vs-Weekly Drinker
7.112800E-01
Daily Drinker-vs-Occasional Drinker
3.449800E-01
Daily Drinker-vs-Social Drinker
2.754800E-01
Weekly Drinker-vs-Occasional Drinker
6.740800E-01
Weekly Drinker-vs-Social Drinker
5.861400E-01
Occasional Drinker-vs-Social Drinker
8.847800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.686970E-01
Normal-vs-Grade 2
2.070500E-02
Normal-vs-Grade 3
3.008500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.855000E-01
Grade 1-vs-Grade 3
3.429400E-01
Grade 1-vs-Grade 4
1.686970E-01
Grade 2-vs-Grade 3
8.608000E-01
Grade 2-vs-Grade 4
2.070500E-02
Grade 3-vs-Grade 4
3.008500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.629400E-01
Normal-vs-NonDiabetic
3.459000E-01
Diabetic-vs-NonDiabetic
5.876000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.341600E-01
Normal-vs-NoPancreatitis
3.533200E-01
Pancreatitis-vs-NoPancreatitis
6.389000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.525600E-01
Normal-vs-N1
3.828600E-01
N0-vs-N1
3.029200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.707200E-01
Normal-vs-TP53-NonMutant
3.481400E-01
TP53-Mutant-vs-TP53-NonMutant
5.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
